Skip to main content
Clinical Trials/NCT03588260
NCT03588260
Completed
Not Applicable

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis: The Relationship With Exercise Capacity, Physical Activity Level, and Quality of Life

Istanbul Medipol University Hospital1 site in 1 country60 target enrollmentJuly 20, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Idiopathic Pulmonary Fibrosis
Sponsor
Istanbul Medipol University Hospital
Enrollment
60
Locations
1
Primary Endpoint
The Quality of Life Questionaire
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Respiratory muscle strength, dyspnea perception, physical activity and quality of life measurements will be performed and groups will be compared in two groups consisting of patients with idiopathic pulmonary fibrosis referred to pulmonary rehabilitation clinic and healthy volunteers in similar age range.

Detailed Description

The patients who have agreed to participate in the study from patients diagnosed with idiopathic pulmonary fibrosis referred to the center of pulmonary rehabilitation from the interstitial lung disease polyclinic will be included in the study. In addition, a healthy adult control group will be established from similar age groups. The two groups will be compared in terms of outcome measures.The study outcome measurements are maximum inspiratory/expiratory muscle strength , international physical activity questionaire, modified Medical Research Council dyspnea scale, Short form 36 quality of lide questionaire, fatigue severity scale, six minute walking test.

Registry
clinicaltrials.gov
Start Date
July 20, 2018
End Date
December 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Istanbul Medipol University Hospital
Responsible Party
Principal Investigator
Principal Investigator

esra pehlivan

Principal investigator

Istanbul Medipol University Hospital

Eligibility Criteria

Inclusion Criteria

  • Between the ages of 18-70
  • Patients signing informed consent form
  • Patients diagnosed with idiopathic pulmonary fibrosis.

Exclusion Criteria

  • Patients who use steroids for less than 1 year
  • The patient does not want to participate in the study

Outcomes

Primary Outcomes

The Quality of Life Questionaire

Time Frame: 20 minutes

Short Form 36

Maximum inspiratory muscle pressure

Time Frame: 15 minutes

The mouth pressure measurement was performed with the Micro-RPM® instrument from SensorMEDIC. Patient placed a rubber mouthpiece with flanges, on the device, sealed their lips firmly around the mouthpiece, exhaled/inhaled slowly and completely, and then tried to breath in as hard as possible. The patient was allowed to rest for about a minute and the maneuver was repeated five times. Verbal or visual feedback was provided after each maneuver. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value was obtained.

Maximum expiratory muscle pressure

Time Frame: 15 minutes

The mouth pressure measurement was performed with the Micro-RPM® instrument from SensorMEDIC. Patient placed a rubber mouthpiece with flanges, on the device, sealed their lips firmly around the mouthpiece, exhaled/inhaled slowly and completely, and then tried to breath in as hard as possible. The patient was allowed to rest for about a minute and the maneuver was repeated five times. Verbal or visual feedback was provided after each maneuver. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value was obtained.

The distance covered in six-minute walk test

Time Frame: 10 minutes

The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were told that they should walk as fast as they can walk. Before and after the test, oxygen saturation, heart rate, Borg fatigue rating, and walking distance were recorded.

International Physical Activity Questionnaire

Time Frame: 15 minutes

The International Physical Activity Questionnaire (IPAQ) was developed as an instrument for cross-national monitoring of physical activity and inactivity. This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting.

Secondary Outcomes

  • The modified Medical Research Council (mMRC) scale(3 minutes)
  • The fatigue severity scale(15 minutes)

Study Sites (1)

Loading locations...

Similar Trials